SCHEMBL22028449

SCHEMBL22028449

C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@]1(O)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 8/20 1.00
▸ HIF1A Q16665 8/20 0.81
▸ CYP3A4 P08684 7/20 0.81
▸ HSD17B10 Q99714 4/20 0.81
▸ NFKB1 P19838 3/20 0.81
▸ PGR P06401 3/20 0.81
▸ TSHR P16473 2/20 0.81
▸ AR P10275 2/20 0.81
▸ PMP22 Q01453 2/20 0.81
▸ MEN1 O00255 1/20 0.81
▸ CYP2D6 P10635 1/20 0.81
▸ KMT2A Q03164 1/20 0.81
▸ APEX1 P27695 1/20 0.81
▸ NPSR1 Q6W5P4 1/20 0.81
▸ IKBKB O14920 1/20 0.81
▸ CHUK O15111 1/20 0.81
▸ ADRB2 P07550 1/20 0.81
▸ NR3C2 P08235 1/20 0.81
▸ PLA2G2A P14555 1/20 0.81
▸ NFKB2 Q00653 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18475630 1.00 NR3C1 (1.00) NR3C1HIF1ACYP3A4HSD17B10NFKB1
SCHEMBL13929942 1.00 NR3C1 (1.00) NR3C1HIF1ACYP3A4HSD17B10NFKB1
SCHEMBL18475425 1.00 NR3C1 (1.00) NR3C1HIF1ACYP3A4HSD17B10NFKB1
SCHEMBL18380070 1.00 NR3C1 (1.00) NR3C1HIF1ACYP3A4HSD17B10NFKB1
SCHEMBL16718939 1.00 NR3C1 (1.00) NR3C1HIF1ACYP3A4HSD17B10NFKB1
SCHEMBL19308807 1.00 NR3C1 (1.00) NR3C1HIF1ACYP3A4HSD17B10NFKB1
SCHEMBL18379414 1.00 NR3C1 (1.00) NR3C1HIF1ACYP3A4HSD17B10NFKB1
SCHEMBL3754621 1.00 NR3C1 (1.00) NR3C1HIF1ACYP3A4HSD17B10NFKB1
SCHEMBL19764184 1.00 NR3C1 (1.00) NR3C1HIF1ACYP3A4HSD17B10NFKB1
SCHEMBL1115827 1.00 NR3C1 (1.00) NR3C1HIF1ACYP3A4HSD17B10NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11447522-B2 Potent soft anti-inflammatory corticosteroid compounds and uses thereof BODOR LABORATORIES, INC. (US) 2022-09-20 — — US disclosed
US-20200181191-A1 POTENT SOFT ANTI-INFLAMMATORY CORTICOSTEROID COMPOUNDS AND USES THEREOF BODOR LABORATORIES, INC. 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181191-A1 POTENT SOFT ANTI-INFLAMMATORY CORTICOSTEROID COMPOUNDS AND USES THEREOF NR3C1, NR3C2, HSD3B1 NR3C1 1/4885HIF1A 1638/4885CYP3A4 334/4885
US-11447522-B2 Potent soft anti-inflammatory corticosteroid compounds and uses thereof NR3C1, NR3C2, HSD3B1 NR3C1 1/4885HIF1A 1638/4885CYP3A4 334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback